CoChat

Stabilisation of atherosclerotic plaques: Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology

Open access
Bentzon, Jacob Fog, Daemen, Mat, Falk, Erling, Garcia-Garcia, Hector M., Herrmann, Joerg, Hoefer, Imo, Jukema, J. Wouter, Krams, Rob, Kwak, Brenda R., Marx, Nikolaus, Naruszewicz, Marek, Newby, Andrew, Pasterkamp, Gerard, Serruys, Patrick W. J. C., Waltenberger, Johannes, Weber, Christian, Tokgözoglu, Lale, Ylä-Herttuala, Seppo · 2011 · Thrombosis and Haemostasis
Cited by 143

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Summary: Plaque rupture and subsequent thrombotic occlusion of the coronary artery account for as many as three quarters of myocardial infarctions. The concept of plaque stabilisation emerged about 20 years ago to explain the discrepancy between the reduction of cardiovascular events in patients receiving lipid lowering therapy and the small decrease seen in angiographic evaluation of atherosclerosis. Since then, the concept of a vulnerable plaque has received a lot of attention in basic and clinical research leading to a better understanding of the pathophysiology of the vulnerable plaque and acute coronary syndromes. From pathological and clinical observations, plaques that have recently ruptured have thin fibrous caps, large lipid cores, exhibit outward remodelling and invasion by vasa vasorum. Ruptured plaques are also focally inflamed and this may be a common denominator of the other pathological features. Plaques with similar characteristics, but which have not yet ruptured, are believed to be vulnerable to rupture. Experimental studies strongly support the validity of anti-inflammatory approaches to promote plaque stability. Unfortunately, reliable non-invasive methods for imaging and detection of such plaques are not yet readily available. There is a strong biological basis and supportive clinical evidence that low-density lipoprotein lowering with statins is useful for the stabilisation of vulnerable plaques. There is also some clinical evidence for the usefulness of antiplatelet agents, beta blockers and renin-angiotensin-aldosterone system inhibitors for plaque stabilisation. Determining the causes of plaque rupture and designing diagnostics and interventions to prevent them are urgent priorities for current basic and clinical research in cardiovascular area.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1160/th10-12-0784

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 143

Metadata

Authors
Bentzon, J. F., Daemen, M., Falk, E., Garcia-Garcia, H. M., Herrmann, J., Hoefer, I., Jukema, J. W., Krams, R., Kwak, B. R., Marx, N., Naruszewicz, M., Newby, A., Pasterkamp, G., Serruys, P. W. J. C., Waltenberger, J., Weber, C., Tokgözoglu, L., & Ylä-Herttuala, S.
Venue
Thrombosis and Haemostasis
Published
2011
Volume
106
Issue
07
Pages
1-19
ISSN
  • 0340-6245 (ISSN-L)
  • 2567-689X
OpenAlex
W1832728002
Cited by
143
References
36
FWCI
9.08
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stabilisation of atherosclerotic plaques: Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology. https://app.cochat.ai/papers/10.1160/th10-12-0784
The paper
Bentzon, J. F., Daemen, M., Falk, E., Garcia-Garcia, H. M., Herrmann, J., Hoefer, I., Jukema, J. W., Krams, R., Kwak, B. R., Marx, N., Naruszewicz, M., Newby, A., Pasterkamp, G., Serruys, P. W. J. C., Waltenberger, J., Weber, C., Tokgözoglu, L., & Ylä-Herttuala, S. (2011). Stabilisation of atherosclerotic plaques: Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology. Thrombosis and Haemostasis. https://doi.org/10.1160/th10-12-0784

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.